By Jake Simpson ( March 4, 2013, 2:23 PM EST) -- Irish life sciences firm Elan Corp. has sweetened its offer to shareholders to remain invested in the company, offering a percentage of Elan's share of royalties from a new drug if investors vote against a $6.6 billion hostile takeover attempt by pharmaceutical investment firm Royalty Pharma LLC, Elan said Monday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.